CCA
STJ

Catalyst Capital Advisors’s St Jude Medical STJ Stock Holding History

Catalyst Capital Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-15,438
Closed -$704K – 329
2013
Q2 		$704K Buy
+15,438
New +$669K 0.55% 57

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Catalyst Capital Advisors's STJ Position: Q3 2013 in Review

Catalyst Capital Advisors sold out of St Jude Medical (STJ) in Q3 2013, closing a stake of 15,438 shares — an estimated $704K sold.

Catalyst Capital Advisors first reported a position in STJ in Q2 2013 and held it in 1 quarter. The position peaked at $704K in Q2 2013. 486 funds tracked by Wall St. Rank hold STJ as of Q3 2013.

  • Catalyst Capital Advisors reported no remaining St Jude Medical position as of Q3 2013 after selling out during the quarter.
  • Catalyst Capital Advisors sold 15,438 St Jude Medical shares in Q3 2013, an estimated $704K.
  • Catalyst Capital Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 1 quarter.
  • Catalyst Capital Advisors's St Jude Medical position peaked at $704K in Q2 2013.
  • 486 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2013.

Based on Catalyst Capital Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.